baber/WOPTO huggingface dataset:
Patent DK-2021046-T3 (DK)
Inventor: JOSHI ASHOK V
IPC: A61M1/00
Filed: 2007-05-10
Granted: 2012-07-02
Abstract: A wound therapy device is disclosed. The wound therapy device may include a housing for covering at least a portion of a wound and for sealing to a body surface of a patient. The housing may also include a liquid collector for retaining liquid therein and a vacuum connection for coupling to a vacuum source. The vacuum connection may be in gaseous communication with the liquid collector. The vacuum connection may be separated from the liquid collector by a liquid barrier.
Patent DK-2103042-T3 (DK)
Inventor: ASHLEY ALEX
IPC: H04W16/06
Filed: 2007-12-14
Granted: 2010-12-06
Abstract: In a system comprising a first access point serving a first wireless network; and a neighboring access point serving a neighboring wireless network having coverage overlapping with the first wireless network, where the first access point and the neighboring access point transmit beacon messages at beacon times that are temporally separated by predetermined beacon periods, a method of operating the system is disclosed, the method comprising: the first access point sending a first offer to the neighboring access point, the first offer offering a period of silent time to the neighboring access point during which period of silent time the first access point silences the first wireless network, the period of silent time being independent of the beacon times and the beacon periods.
Patent DK-1961426-T3 (DK)
Inventor: CONTORNI MARIO
IPC: A61K39/09
Filed: 2004-10-04
Granted: 2011-08-08
Abstract: Addition of a Hib conjugate to meningococcal conjugates enhances the overall activity against meningococcus serogroup W135.
Patent DK-2263660-T3 (DK)
Inventor: SHIMIZU TOSHIHIRO
IPC: A61K31/44
Filed: 1999-05-17
Granted: 2018-01-02
Abstract: An orally disintegrable tablet, of the present invention, which comprises (i) fine granules having an average particle diameter of 400 mu m or less, which fine granules comprise a composition coated by an enteric coating layer, said composition having 10 weight % or more of an acid-labile physiologically active substance and (ii) an additive, has superior disintegrability or dissolution in the oral cavity so that it can be used for treatment or prevention of various diseases, as an orally disintegrable tablet capable of being administered to the aged or children and easily administered without water. Also, because the tablet of the present invention contains fine granules having the average particle diameter such that it will not impart roughness in mouth, it can be administered easily without discomfort at the administration.
Patent DK-2659029-T3 (DK)
Inventor: BARTEL JOSEPH AUGUST
IPC: G01N33/58
Filed: 2011-12-23
Granted: 2018-04-16
Abstract: A population of bright and stable nanocrystals is provided. The nanocrystals include a semiconductor core and a thick semiconductor shell and can exhibit high extinction coefficients, high quantum yields, and limited or no detectable blinking.
Patent DK-2706062-T3 (DK)
Inventor: CHO YOUNG LAG
IPC: C07D501/46
Filed: 2012-03-29
Granted: 2018-08-06
Abstract: The present invention relates to novel cephalosporin derivatives represented by Chemical Formula 1. Wherein, X, Y, L, R1, and R2 are as same as defined in the description of the invention. The present invention also relates to pharmaceutical antibiotic compositions comprising a novel celphalosporin derivative represented by Chemical Formula 1, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof, or a pharmaceutically acceptable salt thereof as an effective ingredient. According to the present invention, novel cephalosporin derivatives, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof, or a pharmaceutically acceptable salt thereof as an effective ingredient for the broad spectrum of antibiotic resistant, low toxicity, particularly in Gram-negative bacteria, which can be useful with strong antimicrobial activity.
Patent DK-2749710-T3 (DK)
Inventor: DU YONGSHENG
IPC: E04F15/04
Filed: 2006-04-14
Granted: 2018-08-27
Abstract: A floor panel comprises a protrusion end face having a protrusion and a recess end face having a recess. The profiles of the protrusion and the recess are allowed to be installed in the following manner: placing the protrusion nearby the recess of an already installed floor panel, and then applying a pressure to introduce the protrusion in the recess. A flooring system allows use of said method to install more than one floor panel. According to the solution of the present invention, the installation and pave of the floor panels is very simple and the installed floor panels do not easily separate.
Patent DK-2874604-T3 (DK)
Inventor: MATHIEU LAURENCE
IPC: A61K9/107
Filed: 2013-07-17
Granted: 2018-05-22
Abstract: The use of an emulsion for protecting the skin against aggressive chemical agents, wherein this emulsion includes at least one amphoteric chelating agent which includes a complex based on aluminium and on ethylenediaminetetraacetic acid or the trisodium salt thereof, having the general formula [Al(Y) Bn]c′Dc with B being OH−, BO2− or H+, Y being a tetracarboxylate which can be protonated four times to form ethylenediaminetetraacetic acid, n being an integer equal to 0, 1, 2 or 3, D being a counterion, preferably Na+, c being an integer equal to 0, 1, 2 or 3 and c′being a relative number having the same absolute value as c.
Patent DK-2859015-T3 (DK)
Inventor: ALVAREZ JUAN
IPC: C12N15/62
Filed: 2013-06-06
Granted: 2018-06-18
Abstract: The present invention provides fusion proteins comprising a mucin-domain polypeptide covalently linked to an active protein that has improved properties (e.g. pharmacokinetic and/or physicochemical properties) compared to the same active protein not linked to mucin-domain polypeptide, as well as methods for making and using the fusion proteins of the invention.
Patent DK-3194701-T3 (DK)
Inventor: ZHANG XUEZHONG
IPC: F16H7/12
Filed: 2015-07-24
Granted: 2018-09-10
Abstract: In one embodiment, the present invention relates to a belt tensioning device for a hollow blind that comprises: a holder seat equipped with a lower belt gear on the top portion of the holder, the holder seat is in clearance fit with a lumen of a side frame of the hollow blind and is provided with a group of V- shaped slots from top to bottom therein, each V-shaped slot is equipped with a clip therein, the slip has a width slightly larger than the width of the lumen of the side frame of the hollow blind when being bent. The present invention allows the belt tensioning device to move along a single direction within the side frame of the hollow blind so that the distance between two belt gears can be gradually adjusted, thereby maintaining a proper tensioning force in the belt.
Patent DK-0393498-T3 (DK)
Inventor: KETTLER HEINZ
IPC: A63B21/00
Filed: 1990-04-11
Granted: 1994-02-07
Abstract: The exercise weights (10), to be applied for different loading, are guided eccentrically over a guide element to a vertical guide tube (6), the guide element being formed by two guide rollers (8), extending spaced apart, with associated straps (9). The spacing of the axles (3) of the guide rollers (8) mounted in the straps (9) is advantageously dimensioned in such a way that the clear spacing between the outside surfaces of the guide rollers (8) is greater than the cross-section of the guide tube (6). Due to the design according to the invention, tilting of the guide element, guided on the vertically extending guide pipe (6), is avoided despite the prevailing eccentric arrangement of the exercise weights (10). To rule out entanglement or looping of the cables of the latissimus exercising equipment and the butterfly station, a cable guide lug (11) is arranged above the cable receptacles for guiding the cables. <IMAGE>
Patent DK-0447999-T3 (DK)
Inventor: GULBINS ERICH DR
IPC: C08F8/00
Filed: 1991-03-16
Granted: 1995-11-06
Abstract: Aqueous binder dispersions obtainable by reacting   a) 1 part by weight of a water-soluble aminoplastic resin or starting compounds thereof (component I) with b) from 0.5 to 20 parts by weight of a copolymer (component II) in aqueous dispersion, containing, per kg, from 0.005 to 5.0 mol of reactive groups which are able to undergo a condensation or addition reaction with the reactive groups of component I, in weakly acidic or basic medium to a degree of conversion at which at least 10% by weight of component I has transferred from the aqueous solution to the disperse phase, and whose upper limit is defined as the point at which the resultant dispersion is just still film-forming.
Patent DK-0488061-T3 (DK)
Inventor: STAUNTON DONALD E
IPC: C07K19/00
Filed: 1991-11-21
Granted: 1999-07-19
Abstract: The present invention relates to intercellular adhesion molecules (ICAM-1) and their interaction with the Mac-1 receptor molecule. The invention relates to the use of these molecules and their functional equivalents in the treatment of inflammation and viral diseases.
Patent DK-0491314-T3 (DK)
Inventor: DELCOUSTAL JEAN-MARIE
IPC: H02G15/08
Filed: 1991-12-16
Granted: 1995-04-10
Abstract: The present invention relates to a bottom arrangement for enclosing high-voltage equipment in gas-insulated metal enclosures, especially for cable connection. The adaptor piece consists of at least two concentric parts (5, 10) connected to one another in tight and dismantleable manner, one (5) of which, termed the first piece, provides the clamping of the insulating (2) socket(s) (4), and another (10) of which, termed the second part, is annular and is connected to the flange (3) of the enclosure (1). This arrangement enables the enclosure to be dismantled without displacing the cable connections. <IMAGE>
Patent DK-0537168-T3 (DK)
Inventor: POMATO NICHOLAS
IPC: A61P35/00
Filed: 1991-04-10
Granted: 1996-09-02
Abstract: The present invention comprises the epitope recognized by the human monoclonal antibody 28A32, the human tumor antigen containing this epitope, which we have identified, isolated and characterized, and human MCA 28A32. The invention also relates to the use of antibodies to the antigen containing this epitope for diagnosis and monitoring of treatment of cancer and to the use of this antigen in the preparation of vaccines to elicit an immune response similar to that obtained against tumor cells containing this epitope.
Patent DK-0550538-T3 (DK)
Inventor: MARSHALL ROBERT A
IPC: D21H27/00
Filed: 1991-08-20
Granted: 1996-07-29
Abstract: Hydrophobic particles containing polar groups on their surfaces are incorporated into a tobacco smoking article to remove deleterious chemical compounds, both polar and non-polar, from the tobacco smoke.
Patent DK-0522365-T3 (DK)
Inventor: COLOMBO PAOLO
IPC: C11D1/72
Filed: 1992-06-26
Granted: 1994-10-24
Abstract: Stable aqueous suspensions of zeolite 4A which can be easily pumped, containing from 0.5 to 65% of zeolite and from 0.05 to 6 g (per 100 g of zeolite) of a suspending agent, composed of mixtures of ethoxylated alkanols, said mixtures being obtained by ethoxylating: a) biodegradable branched alkanols, having from 10 to 18 carbon atoms and having a single branching in position 2, said mixtures containing at least 2 alkanols having a different number of C atoms; or b) mixtures containing 40-100% of branched alkanols as in a) and 60-0% of linear alkanols having from 10 to 18 C atoms.
Patent DK-0535448-T3 (DK)
Inventor: MUELLER RICHARD H
IPC: C07C49/753
Filed: 1992-09-16
Granted: 1996-07-29
Abstract: Racemic Feist's acid is treated with (R)-(+)-a-methylbenzylamine to yield (1R-trans)-3-methylenecyclopropane-1,2-dicarboxylic acid, (R)-a-methylbenzylamine (1:1) salt. This salt can then be converted to (1R-trans)-3-methylene-1,2-cyclopropanedicarboxylic acid, dimethyl ester which is an intermediate in the preparation of the antiviral agent Ä1R-(1a,2b,3a)Ü-2-amino-9-Ä2,3-bis(hydroxymethyl)cyclobutylÜ-1,9-dihyd ro-6H-purin-6-one. The improved process also enables the recovery of racemic Feist's acid from the resolution.
Patent DK-0542034-T3 (DK)
Inventor: GROSS JUERGEN DR
IPC: E05D11/10
Filed: 1992-10-28
Granted: 1995-11-06
Abstract: The subject of the invention is a furniture hinge with a closing and holding-shut mechanism, with a part for fastening on the door and the piece of furniture, and with at least one spring element (5) which acts on at least one articulation lever (2, 3), connecting the hinge parts to each other in an articulated manner, or on a catch-locking member, accommodated in one of the hinge parts, and which, at least shortly before reaching the closed position of the hinge, generates or increases a force component acting in the closing direction of the hinge, adjusting means which act on the spring element and permit a modification of the force component acting in the closing direction being present. The object of the invention is to provide an adjusting member which acts on the spring element of a furniture hinge of this type, is easy and quick to actuate, allows the extent of the spring prestress to be discerned at any time and, requiring little space, can be used for differently designed spring elements or spring systems and/or hinge types. This is achieved in that the adjusting means is a threadless, axially non-displaceable, rotatably mounted shaped body (10) which, during rotation, acts directly or indirectly on the spring element (5) and changes the position of the entire spring element or the position at least of a part (22) of the spring element (5).
Patent DK-0526642-T3 (DK)
Inventor: FUJIMOTO MASAFUMI
IPC: A61K31/00
Filed: 1991-12-13
Granted: 1998-10-19
Abstract: A triterpene derivative represented by general formula (I), which has an antiendotheline activity and is useful for preventing and treating the diseases of the cardiovascular system, and a pharmaceutical composition thereof. In formula (I), R<1> represents hydrogen or a metabolic ester residue; R<3> represents an aryl or aromatic heterocyclic group which may be substituted; one of X and Y is hydroxy and the other is hydrogen, or alternatively X and Y are combined with each other to represent oxo; and Z represents oxygen or two hydrogen atoms. <CHEM>
Patent DK-0587772-T3 (DK)
Inventor: KOUNTZ DENNIS JAMES
IPC: H01L/
Filed: 1992-06-08
Granted: 1997-09-15
Abstract: A superconducting Tl-Pb-Sr-Ca-Cu-O thin film comprised of at least one phase of the formula Tl0.5Pb0.5Sr2Ca1+nCu2+nO7+2n where n=0, 1 or 2 is disclosed, which is prepared by a process comprising sputtering an oxide film onto a dielectric substrate from an oxide target containing preselected amounts of Tl, Pb, Sr, Ca and Cu, and heating an oxygen-containing atmosphere in the deposited film in the presence of a source of thallium oxide and lead oxide and cooling the film.
Patent DK-0585425-T3 (DK)
Inventor: KRAMM RUEDIGER
IPC: E04F11/00
Filed: 1993-02-19
Granted: 1998-05-25
Abstract: A building (1) is described with floor levels (5) on which there are shop units or the like (6) and which are at least partially connected by, among other things, continuously ascending ramps (7). In order to accommodate the greatest possible number of shop units or the like in a limited area which does not allow a communicating surface design, it is envisaged that the building (1) should be constructed on pillars (2), to which are fixed girders (3) with inlaid trapezoidal surfaces (4) in such a way that the difference in height between adjacent girders (3) is such that for a given center distance between pillars (2) a ramp (7) of constant gradient will have a gradient of not substantially more than 6 %, and the ramp (7) will extend in an approximate spiral throughout the main vertical extent of the building (1).
Patent DK-0638089-T3 (DK)
Inventor: SHORTLE DAVID R
IPC: C07H21/00
Filed: 1993-04-13
Granted: 2001-07-16
Abstract: A new technique for generating mixtures of oligonucleotides in a single automated synthesis is taught. The method can be used to prepare mixed oligonucleotides ideally suited for creation of useful mixtures of oligo- or polypeptides or proteins. Additionally, the technique enables insertion and/or substitution and/or deletion of a nucleotide sequence at one or more sites. For protein mutagenesis, a trinucleotide can be inserted or substituted at codon boundaries. The invented technique makes possible the encoding of all possible single amino acid insertions, or any desired mixture of substitutions and insertions.
Patent DK-0642307-T3 (DK)
Inventor: NIELSEN PER MUNK
IPC: A23J3/34
Filed: 1993-05-26
Granted: 1998-09-07
Abstract: The method for production of a whey protein hydrolyzate comprises the use of a whey protein product produced by acidic precipitation of casein as a starting material and combined with a non-pH-stat hydrolysis. The method provides a well tasting and organoleptically acceptable product with low allergenicity in high yield.
Patent DK-0632028-T3 (DK)
Inventor: SUZUKI TOSHIMITSU
IPC: C07C69/63
Filed: 1993-10-21
Granted: 2003-07-21
Abstract: A highly pure, optically active 2-nitroimidazole derivative that can be used as a concomitant drug for the radiotherapy of various tumors because it has an excellent radiosensitizing effect and a high safety. It can be produced from an inexpensive diester of tartaric acid in a high yield according to reaction scheme (I), wherein R<1> and R<2>, which may be the same or different from each other, represent each an aliphatic or aromatic group, and X represents halogen. <CHEM>
Patent DK-0648896-T3 (DK)
Inventor: THOMASSEY BERNARD
IPC: E01C11/22
Filed: 1994-10-11
Granted: 2000-07-03
Abstract: This water guide strip comprises a flexible prefabricated body (1) based on ground rubber particles, in particular recycled ground rubber, and rock granulates or ground plastic waste, these particles and these granulates or this ground waste being agglomerated by a binder, the said strip being bonded onto the surfacing of the roadway. Application to the verges of motorways. <IMAGE>
Patent DK-0675895-T3 (DK)
Inventor: IMBERT THIERRY
IPC: C07H17/04
Filed: 1993-12-20
Granted: 1998-02-23
Abstract: PCT No. PCT/FR93/01270 Sec. 371 Date Jun. 21, 1995 Sec. 102(e) Date Jun. 21, 1995 PCT Filed Dec. 20, 1993 PCT Pub. No. WO94/14829 PCT Pub. Date Jul. 7, 1994Compound of the formula (I) in which R' is a hydrogen atom or a radical R and R is an acyl residue. The invention also concerns the use of said compounds in the treatment of cancer and pharmaceutical compositions comprising said compounds.    <IMAGE>  I
Patent DK-0706330-T3 (DK)
Inventor: ROUMAGNAC JEAN-PATRICK
IPC: A61L2/06
Filed: 1994-06-28
Granted: 1997-12-08
Abstract: PCT No. PCT/FR94/00778 Sec. 371 Date Dec. 28, 1995 Sec. 102(e) Date Dec. 28, 1995 PCT Filed Jun. 28, 1994 PCT Pub. No. WO95/01107 PCT Pub. Date Jan. 12, 1995The invention relates to a rotary drum structure for a sterilizer. The structure includes: four beams (30, 32, 34, 36) disposed parallel to said axis and defining a rectangular parallelepiped volume; a plurality of spacer elements (52, 54, 56) disposed in the four faces defining said parallelepiped volume and forming triangulated structures; a second end part (60) fixed to second ends of the beams to define an inlet opening (64) into said drum; and a circular running path (62).
Patent DK-0689841-T3 (DK)
Inventor: INAGI TOSHIO
IPC: A61K31/70
Filed: 1995-06-09
Granted: 2003-02-24
Abstract: A powder preparation for healing damaged skins, which comprises 50-90 wt.% of sucrose, 0.5-10 wt.% of povidone-iodine, and a water-soluble polymer selected from the group consisting of polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acid and salts thereof, pullulan, carboxyvinyl polymers, methylcellulose, hydroxymethylcellulose, hydroxypropylmethylcellulose, and carboxymethylcellulose and salts thereof, is disclosed. The powder preparation features that it undergoes no caking even when vibrated upon its transportation or the like or stored for a long period of time, does not scatter upon its use, and has good adhesion to wound surfaces.
Patent DK-0674831-T3 (DK)
Inventor: VAN DEN BERG KAREL
IPC: A01C17/00
Filed: 1995-03-14
Granted: 2001-01-29
Abstract: The invention relates to a method of using an implement for spreading a material under the control of a microprocessor (2). In the microprocessor (2), a desired amount of material to be spread per unit of time (7) is defined on the basis of values introduced into the microprocessor (2). Furthermore, before spreading the material, a pre-determined adjustment factor (9) attuned to the type of material to be spread is introduced into the microprocessor (2) and used to adapt the defined value of the desired amount of material per unit of time (7). The adapted value is used for the control of a metering device (1) through the intermediary of a standard characteristic attuned to the type of implement and/or algorithm, both stored in the microprocessor (2). During the spreading of material, on account of signals produced by a weight measuring unit (32) and which represent the decrease in weight of the material, the value related to, and adapted to the desired amount of material per unit of time (10) is corrected if it deviates from the measured amount of material spread per unit of time. <IMAGE>
Patent DK-0685560-T3 (DK)
Inventor: YABUTA MASAYUKI
IPC: C12P21/00
Filed: 1995-05-31
Granted: 2008-07-14
Abstract: In a lactose repressor protein, at least one amino acid at the position of 94, 241, 265 or 300 in the wild lactose repressor is replaced with an amino acid other than that of the wild lactose repressor, and the use thereof. The present mutant lactose repressor represses the expression of a desired gene at 30 DEG C or lower temperature, and induces the expression of a desired gene at 37 DEG C or higher temperature, and therefor can control the expression by change of a culture temperature without using an expensive inducer such as IPTG.
Patent DK-0713865-T3 (DK)
Inventor: LASSALLE GILBERT
IPC: C07C309/87
Filed: 1995-11-21
Granted: 1999-09-20
Abstract: Cpds. of formula (I) are new. In (I), R4 i H, halo or NO2; R6 is H or 1-6C alkyl; R7 is Cl or OH; and Z is I (when R7 is Cl), phenyl (opt. substd. by one or more halo; 1-4C alkyl or alkoxy; CF3; formyl; CH2OR; CH2OCOR; CH2CONRR'; CHONCOR; COOR; NO2; NHR; NRR' or NHCOR), heterocycle such as pyridinyl, thienyl, furyl, thiazolyl and pyrimidyl (opt. substd. as above) or 5-8C cycloalkyl when R7 is Cl or OH (free or as an alkali metal or tert. amine salt); and R and R' are H or 1-7C alkyl.
Patent DK-0779839-T3 (DK)
Inventor: GLEHN ANDREAS VON
IPC: B03C3/30
Filed: 1995-06-06
Granted: 2000-11-13
Abstract: PCT No. PCT/SE95/00653 Sec. 371 Date Dec. 6, 1996 Sec. 102(e) Date Dec. 6, 1996 PCT Filed Jun. 6, 1995 PCT Pub. No. WO95/33569 PCT Pub. Date Dec. 14, 1995A particle separating arrangement includes a filter tube (1) that is made of electrostatically chargeable fibres, for instance electrete fibres, and through which an axial air stream can pass radially in a direction from within outwardly. Within the tube (1) an insert (2) is placed, including a carrier (3) which extends transversely to the tube, the carrier having a plurality of strip elements (4) arranged to be set in motion by the passing air stream and thereby be rubbed against each other in order to produce an electrostatically charged field in their environs. This field is used to automatically and continuously keep the chargeable fibres in the filter tube wall (1) electrostatically charged.